grantor: University of TorontoMalignant hyperthermia (MH) and central core disease (CCD) are autosomal dominant disorders of skeletal muscle in which a potentially fatal hypermetabolic crisis can be triggered by commonly used anesthetic agents. To date, seventeen mutations in the human RYR1 gene encoding the Ca2+ release channel of skeletal muscle sarcoplasmic reticulum (the ryanodine receptor or RyR1) have been associated with MH and/or CCD. The hypotheses tested in this thesis was that MH and CCD mutations increase the sensitivity of mutant Ca2+ release channels to caffeine and halothane; that MH and CCD mutations increase the permeability (leakiness) of the mutant channels; and that CCD mutant channels are more leaky than MH ch...
Malignant hyperthermia (MH), an inherited neuromuscular disease triggered by halogenated inhalationa...
Malignant hyperthermia (MH) is a potential fatal hereditary skeletal muscle disorder that occurs upo...
Dysregulation of calcium signals due to defects of skeletal muscle sarcoplasmic reticulum calcium re...
grantor: University of TorontoMalignant hyperthermia (MH) and central core disease (CCD) a...
Malignant hyperthermia (MH) and central core disease (CCD) are caused by mutations in the RYR1 gene ...
Malignant hyperthermia (MH) and central core disease (CCD) are caused by mutations in the RYR1 gene ...
Malignant hyperthermia (MH) and central core disease (CCD) are caused by mutations in the RYR1 gene ...
The type 1 ryanodine receptor (RyR1) is a Ca2+ release channel in the sarcoplasmic reticulum of skel...
<div><p>The type 1 ryanodine receptor (RyR1) is a Ca<sup>2+</sup> release channel in the sarcoplasmi...
Single sarcoplasmic reticulum (SR) Ca2+ release channels were reconstituted from normal and malignan...
Malignant hyperthermia (MH), an inherited neuromuscular disease triggered by halogenated inhalationa...
Malignant hyperthermia (MH) is a potentially fatal pharmacogenetic disorder of skeletal muscle that ...
Malignant hyperthermia (MH) is a potentially fatal pharmacogenetic disorder of skeletal muscle that ...
Malignant hyperthermia (MH) is a potentially fatal pharmacogenetic disorder of skeletal muscle that ...
Malignant hyperthermia (MH) is a potentially lethal condition that is manifested in humans as an acu...
Malignant hyperthermia (MH), an inherited neuromuscular disease triggered by halogenated inhalationa...
Malignant hyperthermia (MH) is a potential fatal hereditary skeletal muscle disorder that occurs upo...
Dysregulation of calcium signals due to defects of skeletal muscle sarcoplasmic reticulum calcium re...
grantor: University of TorontoMalignant hyperthermia (MH) and central core disease (CCD) a...
Malignant hyperthermia (MH) and central core disease (CCD) are caused by mutations in the RYR1 gene ...
Malignant hyperthermia (MH) and central core disease (CCD) are caused by mutations in the RYR1 gene ...
Malignant hyperthermia (MH) and central core disease (CCD) are caused by mutations in the RYR1 gene ...
The type 1 ryanodine receptor (RyR1) is a Ca2+ release channel in the sarcoplasmic reticulum of skel...
<div><p>The type 1 ryanodine receptor (RyR1) is a Ca<sup>2+</sup> release channel in the sarcoplasmi...
Single sarcoplasmic reticulum (SR) Ca2+ release channels were reconstituted from normal and malignan...
Malignant hyperthermia (MH), an inherited neuromuscular disease triggered by halogenated inhalationa...
Malignant hyperthermia (MH) is a potentially fatal pharmacogenetic disorder of skeletal muscle that ...
Malignant hyperthermia (MH) is a potentially fatal pharmacogenetic disorder of skeletal muscle that ...
Malignant hyperthermia (MH) is a potentially fatal pharmacogenetic disorder of skeletal muscle that ...
Malignant hyperthermia (MH) is a potentially lethal condition that is manifested in humans as an acu...
Malignant hyperthermia (MH), an inherited neuromuscular disease triggered by halogenated inhalationa...
Malignant hyperthermia (MH) is a potential fatal hereditary skeletal muscle disorder that occurs upo...
Dysregulation of calcium signals due to defects of skeletal muscle sarcoplasmic reticulum calcium re...